Cancer chemopreventive activity mediated by 4'-bromoflavone, a potent inducer of phase II detoxification enzymes

Cancer Research

Volumn 59, Issue 3, 1999, Pages 578-585

  Song, Lynda L ^a   Kosmeder II, Jerome W ^a   Lee, Sang Kook ^a   Gerhäuser, Clarissa ^a,c   Lantvit, Daniel ^b   Moon, Richard C ^b   Moriarty, Robert M ^a   Pezzuto, John M ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4' BROMOFLAVONE; FLAVONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PREVENTION; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DETOXIFICATION; ENZYME INDUCTION; HEPATOMA CELL; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CYTOCHROME P-450 CYP1A1; ENZYME INDUCTION; FEMALE; FLAVONOIDS; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLIC DETOXICATION, DRUG; MICE; PACLITAXEL; RATS; RATS, SPRAGUE-DAWLEY; TAXOIDS; TUMOR CELLS, CULTURED;

EID: 0033083919     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Sporn, M. B., and Newton, D. L. Chemoprevention of cancer with retinoids. Fed. Proc., 38: 2528-2534, 1979.
2. Hong, W. K., and Sporn, M. B. Recent advances in chemoprevention of cancer. Science (Washington DC), 278: 1073-1077, 1997.
3. Kelloff, G. J., Boone, C. W., Malone, W. F., and Steele, V. E. Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute. In: L. Wattenberg, M. Lipkin, C. W. Boone, and G. J. Kelloff (eds.), Cancer Chemoprevention, pp. 41-56. Boca Raron, FL: CRC Press, 1992.
4. Wattenberg, L. W. An overview of chemoprevention: current status and future prospects. Proc. Soc. Exp. Biol. Med., 216: 133-141, 1997.
5. Talalay, P., De Long, M. J., and Prochaska, H. J. Molecular mechanisms in protection against carcinogenesis. In: J. G. Cory and A. Szentivanyi (eds.), Cancer Biology and Therapeutics, pp. 197-216. New York: Plenum Press, 1981.
6. 1-induced preneoplastic foci in a rat model of hepatic tumorigenesis. Carcinogenesis (Lond.), 14: 2423-2425, 1993.
7. Lam, L. K. T., Sparnins, V. L., and Wattenberg, L. W. Isolation and identification of kahweol palmitate and cafestal palmitate as active constituents of green coffee beans that enhance glulathione S-transferase activity in mouse. Cancer Res., 42: 1193-1198, 1982.
8. Wattenberg, L. W., and Bueding, E. Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) on carcinogenesis induced by benzo|a|pyrene, dithylnitrosamine and uracil mustard. Carcinogenesis (Lond.), 7: 1379-1381, 1986.
9. Zhang, Y., Kensler, T. W., Cho, C. G., Posner, G. H., and Talalay, P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanares. Proc. Natl. Acad. Sci. USA, 91: 3147-3150, 1994.
10. Mehta, R. G., Liu, J., Constantinou, A., Thomas, C. F., Hawthorne, M., You, M., Gerhäuser, C., Pezzuto, J. M., Moon, R. C., and Moriarty, R. M. Cancer chemopreventive activity of brassinin, a phyroalexin from cabbage. Carcinogenesis (Lond.), 16: 399-404, 1995.
11. Kennelly, E. J., Gerhäuser, C., Song, L. L., Graham, J. G., Beecher, C. W. W., Pezzuto, J. M., and Kinghorn, A. D. Induction of quinone reductase by withanolides isolated from Physalis philadelphica (tomatillos). J. Agric. Food Chem., 45: 3771-3777, 1997.
12. Gerhäuser, C., You, M., Liu, J., Moriarty, R. M., Hawthorne, M., Mehta, R. G. Moon, R. C., and Pezzuto, J. M. Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res., 57: 272-278, 1997.
13. Cheng, L. C., Gerhäuser, C., Song, L. L. Farnsworth, N. R., Pezzuto, J. M., and Kinghorn, A. D. Activity-guided isolation of constituents of Tephrosia purpurea with the potential to induce the phase II enzyme, quinone reductase. J. Nat. Prod., 60: 869-873, 1997.
14. Havsteen, B. Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol., 32: 1141-1148, 1983.
15. Chan, S. C,. Chang, Y. S., Wang, J. P., Chen, S. C., and Kuo, S. C. Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Med., 64: 153-158, 1998.
16. Kuo, S. M. Dietary flavonoid and cancer prevention: evidence and potential mechanism. Crit. Rev. Oncol., 8: 47-69, 1997.
17. Ares, J. J., Outt, P. E., Randall, J. L., Murray, P. D., Weisshaar, P. S., O'Brien, L. M., Ems, B. L., Kakodkar, S. V., Kelm, G. R., Kershaw, W. C., Werchowski, K. M., and Parkinson, A. J. Synthesis and biological evaluation of substituted flavones as gastroprotective agents. Med. Chem., 38: 4937-4943, 1995.
18. De Meyer, N., Haemers, A., Mishra, L. Pandey, H. K., Pieters, L. A. C., Vanden Berghe, D. A., and Vlietinck, A. J. 4'-Hydroxy-3-methoxyflavonec with potent anti-picomavirus activity. Med. Chem., 34: 736-746, 1991.
19. Yamashita, Y., Kawada, S., and Nakano, H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobal. Biochem. Pharmacol., 39: 737-744, 1990.
20. Ferriola, P., Cody, V., and Middleton, E., Jr. Protein kinase C inhibition by plant flavonoids. Biochem. Pharmacol., 38: 1617-1624, 1989.
21. Wall, M. E., Wani, M. C., Manikumar, G., Abraham, P., Taylor, H., Hughes, T. J., Warner, J., and McGivney, R. Plant antimutagenic agents, 2. Flavonoids. J. Nat. Prod., 51: 1084-1091, 1988.
22. Leibovitz, B. E., and Mueller, J. A. Bioflavonoids and polyphenols: medical application. J. Optima Nutr., 2: 17-35, 1993.
23. Wattenberg, L. W., and Leong, J. L. Inhibition of the carcinogenic action of benzo[a]pyrene by flavones. Cancer Res., 30: 1922-1925, 1970.
24. Hoshino, Y., and Takeno, N. A new synthesis of flavones using sulfur. Bull. Chem. Soc. Jpn., 59: 2903-2904, 1986.
25. Doshi, A. G., Soni, P. A., and Ghiya, B. Oxidation of 2'-hydroxychalcones. J. Ind. Chem., 25B: 759, 1986.
26. Patonay, T., Litkei, G., and Bognar, R. Flavonoids, XXXIV. Nucleophilic addition in 3-(alkyl) and 3-(arylsulfonyloxyl))flavanones; a new method for synthesis of 3-amin-oflavanones. Acta Chim. Acad. Sci. Hung., 108: 135-146, 1981.
27. Prochaska, H. J., and Santamaria, A. B. Direct measurement of NAD(P)H:quinone reductase from cells in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal. Biochem., 169: 328-336, 1988.
28. 1-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants. Carcinogenesis (Lond.), 8: 1549-1553, 1987.
29. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual, pp. 16.66-16.67. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1986.
30. Chen, S., Clarke, P. E., Martino, P. A., Deng, P. K., Yeh, C. H., Lee, T. D., Prochaska, H. J., and Talalay, P. Mouse liver NAD(P)H:quinone acceptor oxidoreductase: protein sequence analysis by tandem mass spectrometry, cDNA cloning, expression in Escherichia coli, and enzyme activity analysis. Proc. Sci., 3: 1296-1304, 1994.
31. Ryan, D. E., Lu, A. H., and Levin, W. Purification of cytochrome P-450 and P-448 from rat liver microsomes. Methods Enzymol., 52: 117-123, 1978.
32. Rodrigues, A. D., and Pough, R. A. Induction of cytochromes P4501A1 and P4501A2 and measurement of catalytic activities. Methods Enzymol., 206: 423-431, 1991.
33. Poul, R. J., and Fouts, J. R. A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal. Biochem., 107: 265-275, 1980.
34. Sharma, S., Stutzman, J. D., Kelloff, G. J., and Steele, V. E. Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res., 54: 5848-5855, 1994.
35. Swedmark, S., Romert, L., Morgenstern, R., and Jenssen, D. Studies on glutathione transferases belonging to class π in cell lines with different capacities for conjugating (+)-7β,8α-dihydroxy-9α, 10α-oxy-7,8,9,10-tetrahydroxy-benzo[a]pyrene. Carcinogenesis (Lond.), 13: 1719-1723, 1992.
36. Moon, R. C., and Mehta, R. G. Chemoprevention of experimental carcinogenesis in animals. Prev. Med., 18: 576-591, 1989.
37. De Long, M. J., Prochaska, H. J., and Talalay, P. Tissue specific indunction patterns of cancer-protective enzymes in mice by tert-butyl-4-hydroxyanisole and related substituted phenols. Cancer Res., 45: 546-551, 1985.
38. Kensler, T. W., Groopman, J. D., and Roebuck, B. D. Chemoprevention by oltipraz and other dithiolethiones. In: L. Wattenberg, M. Lipkin, C. Boone, and G. Kelloff (eds.), Cancer Chemoprevention, pp. 205-225, Boca Raton. FL: CRC Press, 1992.
39. Grubbs, C., Steele, V. E., Caseblot, T., Juliana, M. M., Eto, I., Whitaker, L. M., Dragnev, K. H., Kelloff, G. L., and Lubet, R. L. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res., 15: 709 716, 1995.
40. 1 in rats. Cancer Lett., 19: 125-132, 1983.
41. 1-hepatocarcinogenesis in rats by β-naphthoflavone. Carcinogenesis (Lond.), 6: 675-678, 1985.
42. Prochaska, H. J., Bregman, H. S., De Long, M. J., and Talalay, P. Specificity of induction of cancer protective enzymes by analogues of tert-butyl-4-hydroxyanisole (BHA). Biochem. Pharmacol., 34: 3909-3914, 1985.
43. Glusker, J. P., and Rossi, M. Molecular aspects of chemical carcinogens and bioflavonoids, In: V. Cody, J. E. Middleton, and J. B. Harborne (eds.), Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships, pp. 395-410. New York: Alan R. Liss, Inc., 1985.
44. Williams, R. T. Comparative patterns of drug metabolism. Fed. Proc., 26: 1029-1039, 1967.
45. Yang, C. S., Smith, T. J., and Hong, J. Y. Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res., 54 (Suppl.): 1982s-1986s, 1994.
46. Barch, D. H., and Rundhaugen, L. M. Ellagic acid induces NAD(P)H:quinone reductase through activation of the antioxidant responsive element of the rat NAD-(P)H:quinone reductase gene. Carcinogenesis (Lond.), 15: 2065-2068, 1994.
47. Anderson, L. M., Jones, A. B., and Kovatch, R. M. Effect of pretreatment with on tumorigenesis by N-nitrosocthylurea in five mouse strains. Cancer Lett., 52: 91-94, 1990.
48. 1-hepatocarcinogenesis in rats by β-naphthoflavone. Carcinogenesis (Lond.), 6: 675-678, 1985.
49. Huggins, C., Grand, L. C., and Brillantes, F. P. Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature (Lond.), 189: 204-207, 1987.
50. Grover, P. L. Pathway involved in the metabolism and activation of polycyclic hydrocarbons. Xenobiotica. 16: 915-931, 1986.
51. Wislocki, P. G., Gadek, K. M., Chou, M. W., Yang, S. K., and Lu, Y. H. Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives. Cancer Res., 40: 3661-3664, 1980.
52. McCord, A., Burnett, A. K., Wolf, C. R., Morrison, V. M., and Craft, J. A. Role of specific cytochrome P450 isoenzymes in the regio-selective metabolism of 7,12-dimethylbenz(a)anthracene in microsomes from rats treated with phenobarbital or Sudan III. Carcinogenesis (Lond.), 9: 1485-1491, 1988.
53. Morrison, V. M., Burnett, A. K., and Craft, J. A. Metabolism of 7,12-dimethylbenz(a)anthracene in hepatic microsomal membranes from rats treated with isoenzyme-selective inducers of cytochrome P450. Bioehem. Pharmacol., 41: 1505-1512, 1991.
54. Lu, Y. F., Santostefano, M., Cunningham, B. D. M., Threadgill, M. D., and Safe, S. Substituted flavones as aryl hydrocarbon (Ah) receptor agonist and antagonist. Biochem. Pharmacol., 51: 1077-1087, 1996.
55. De Flora, S.m and Ramel, C. Mechanisms of inhibition of mutagenesis and carcinogenesis: classification and overview. Mutat. Res., 202: 285-306, 1988.
56. Mannervik, B. The isozymes of glutathione transferase. In: A. Meister (ed.), Advances in Enzymology, pp. 357-417. New York, NY: John Wiley & Sons, 1985.
57. Meyer, J. D., Coles, B., Pemble, S. E., Gilmore, K. S., Fraser, G. M., and Ketterer, B. Theta, a new class of GSH transferases purified from rat and man. Biochem. J., 274: 337-384, 1991.
58. Morrison, V. M., Burnett, A K., and Craft, J. A. Metabolism of 7,12-dimethylbenz[a]anthracene in hepatic microsomal membranes from rats treated with isoenzyme-selective inducers of cytochrome P450. Biochem. Pharmacol., 41: 1505-1512, 1991.
59. Song, L. L., Kosmeder, J. W., Gerhäuser, C., Lantvit, D., Moon, R. C., Moriarty, R. M., and Pezzuto, J. M. 4'-Bromoflavone, a potential chemopreventive agent that strongly induces phase 2 enzymes. Proc. Am. Assoc. Cancer Res., 39: 266, 1998.